4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001501697-26-000078
Chief Financial Officer sold 11,767 shares at $2.86 ($33,658)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIRSKE DAVID Chief Financial Officer | 2026-10-01 | Sale | −11,767 | $2.86 | $33,658 | 155,983 | D |
| Open-market sales · 11,767 sh · avg $2.86 · $33,658 | |||||||
Loading xslF345X06/wk-form4_1791230611.xml…